ArticlePeerJ2025
Expression of Vascular Endothelial Growth Factor and Interleukin-6 in bile duct healing with autologous parietal peritoneum: a non-inferiority experimental study in rabbits.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bile duct injury (BDI) remains a serious complication of hepatobiliary surgery, particularly in laparoscopic cholecystectomy, often leading to strictures, fibrosis, and long-term morbidity. Although traditional repair techniques such as primary suturing and Roux-en-Y hepaticojejunostomy are widely used, they carry risks of anastomotic complications and bile duct dysfunction. Autologous peritoneum has emerged as a potential alternative graft material due to its biocompatibility and regenerative properties. This study evaluates the efficacy of autologous parietal peritoneum graft in bile duct healing, focusing on fibroblast activity, vascular endothelial growth factor (VEGF), and interleukin-6 (IL-6) expression as indicators of tissue remodeling. Materials and Methods: This experimental study involved 27 male New Zealand rabbits ( Results: On day 3, fibroblast infiltration was significantly lower in the autologous peritoneum group ( Conclusion: Autologous peritoneum supports gradual bile duct healing, despite initial delayed fibroblast recruitment, with histological evidence of progressive tissue remodeling. However, the lack of significant differences in VEGF and IL-6 levels suggests that angiogenesis and inflammation were similarly regulated across groups. Given the study's short follow-up period, further research is needed to assess the long-term integration, functional outcomes, and potential benefits of autologous peritoneum in bile duct reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.